|
Market Closed -
Nasdaq
21:00:00 31/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 2.640 USD | -0.38% |
|
-1.86% | +28.16% |
| 07-31 | Cerus Corporation, Q2 2026 Earnings Call, Jul 30, 2026 | |
| 07-30 | Cerus Corporation Revises Earnings Guidance for the Year 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Medical Devices & Implants
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 534M | - | - | - | ||
| 127B | |||||
| 12.12B | |||||
| 10.6B | - | ||||
| 4.22B | |||||
| 2.72B | - | - | - | - |
- Stock Market
- Stocks
- CERS Stock
- Charts Cerus Corporation
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
